Preliminary Risk-Benefit Assessment of Mycophenolate Mofetil in Transplant Rejection
- 1 August 1997
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 17 (2), 75-92
- https://doi.org/10.2165/00002018-199717020-00001
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat.1996
- Mycophenolic Acid: Measurement and Relationship to Pharmacologie EffectsTherapeutic Drug Monitoring, 1995
- Characterization of human type I and type II IMP dehydrogenases.Journal of Biological Chemistry, 1993
- Mechanisms of Action of Mycophenolic AcidAnnals of the New York Academy of Sciences, 1993
- Therapy of rheumatoid arthritis with mycophenolate mofetil.1993
- Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.1991
- RS-61443 allows islet allografting and specific tolerance induction in adult mice.1990
- Purification, characterization, and kinetic analysis of inosine 5′-monophosphate dehydrogenase of Tritrichomonas foetusMolecular and Biochemical Parasitology, 1987
- The inhibition of nucleic acid synthesis by mycophenolic acidBiochemical Journal, 1969
- MYGOPHENOLIG ACID : ANTIVIRAL AND ANTITUMOR PROPERTIESThe Journal of Antibiotics, 1968